Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

American Brain Tumor Association

CharityWatch report issued
October 2020

Top-Rated Charity
CharityWatch Grade
Our independent grade based
on a number of factors.
Program Percentage
Amount spent on programs
relative to overhead.
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

American Brain Tumor Association
8550 W Bryn Mawr Ave
Suite 550
Chicago, IL 60631-3225

Other Names


Tax Status




Stated Mission

To advance the understanding and treatment of brain tumors with the goals of improving, extending and, ultimately, saving the lives of those impacted by a brain tumor diagnosis.

View similar charities
Against Malaria Foundation  
ALS Association (National Office)  
American Diabetes Association  
American Heart Association  
American Kidney Fund  
American Leprosy Missions  
American Liver Foundation  
American Lung Association  
American Parkinson Disease Association  
American Sexual Health Association  
Arthritis Foundation  
Bone Health and Osteoporosis Foundation  
BrightFocus Foundation  
CDC Foundation  
Christopher & Dana Reeve Foundation  
City of Hope & Affiliates  
Crohn's & Colitis Foundation  
Cystic Fibrosis Foundation  
Defeat Diabetes Foundation  
Diabetes Action Research and Education Foundation  
Diabetes Research & Wellness Foundation  
Diabetes Research Institute Foundation  
Easterseals (National Office)  
Elizabeth Glaser Pediatric AIDS Foundation  
Epilepsy Foundation  
Foundation for AIDS Research (amfAR)  
Hearing Health Foundation  
Heart Center of America (DISSOLVED)  
Huntington's Disease Society of America  
JDRF International  
Lupus Foundation of America (National Office)  
Lupus Research Alliance  
March of Dimes  
MedicAlert Foundation United States  
Mercy Ships & Affiliates  
Michael J. Fox Foundation for Parkinson's Research  
Miracle Flights  
Movember Foundation  
Multiple Sclerosis Association of America  
Multiple Sclerosis Foundation  
Muscular Dystrophy Association  
National Caregiving Foundation  
National Emergency Medicine Association (DISSOLVED)  
National Hemophilia Foundation (National Office)  
National Jewish Health  
National Kidney Foundation  
National Multiple Sclerosis Society  
National Psoriasis Foundation  
Operation Smile  
Parkinson Research Foundation  
Parkinson's Foundation  
Partnership for a Healthier America  
PKD Foundation  
Project Cure  
Salk Institute for Biological Studies  
San Francisco AIDS Foundation  
Shriners Hospitals for Children  
Smile Train  
United Cerebral Palsy (National Office)  
Will Rogers Motion Picture Pioneers Foundation  
WonderWork (DISSOLVED)  
Data based on Fiscal Year Ended 12/31/2019

Program Percentage: 71%

The percentage of American Brain Tumor Association's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).


Calculated Total Expenses



Cost to Raise $100: $15

How many dollars American Brain Tumor Association spends on fundraising to raise each $100 of contributions.


Calculated Total Contributions


Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources


Financial Documents

Entity Document Type Tax ID
American Brain Tumor Association IRS Form 990 23-7286648
American Brain Tumor Association Audited Financial Statements 23-7286648
Entity: American Brain Tumor Association
Document Type: IRS Form 990
Tax ID: 23-7286648
Entity: American Brain Tumor Association
Document Type: Audited Financial Statements
Tax ID: 23-7286648

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
American Brain Tumor Association
meets governance benchmarks.
American Brain Tumor Association
meets transparency benchmarks.
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy

  Name Title Compensation
1 Ralph Devitto President/CEO $245,460
2 Kelly Sitkin Chief Development Officer $172,756
3 Nicole Willmarth Chief Mission Officer $151,962
Name: Ralph Devitto
Title: President/CEO
Compensation: $245,460
Name: Kelly Sitkin
Title: Chief Development Officer
Compensation: $172,756
Name: Nicole Willmarth
Title: Chief Mission Officer
Compensation: $151,962

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

In an email correspondence with CharityWatch dated 9/2/2020, the Senior Director, Finance and Audit for the American Brain Tumor Association (ABTA) confirmed that the ABTA 2019 IRS Form 990 tax filing, signed and dated 8/6/2020 by ABTA's President & CEO, contains an error in Part IX, the Statement of Functional Expenses. More specifically, the reported "Management and general expenses" in Part IX, column (C) and the reported "Fundraising expenses" in Part IX, column (D) have been transposed. In other words, column (C), with a reported total of $900,356, consists of ABTA's reported Fundraising expenses, and column (D), with a reported total of $794,388, consists of ABTA's reported Management & General expenses.

ABTA's Senior Director, Finance and Audit confirmed that the ABTA audited Statement of Functional Expenses for the year ended December 31, 2019 reports the correct Fundraising and Management & General expenses.

According to the American Brain Tumor Association (ABTA) audit of December 31, 2019 (Note B10, Donated Items and Services), ABTA received in-kind donated items and services in 2019 on which it placed a total value of $62,117.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to the American Brain Tumor Association (ABTA) audit of December 31, 2019 (Note O, Subsequent Events):

"The direct and indirect impacts of the current COVID-19 outbreak on ABTA's donors, vendors, operations, and financing agreements are currently unknown, as is the duration and severity of any impacts that the ABTA may experience. Management is currently unable to quantify the effects that this situation will have on its operations and financial position; however they may be significant.

"The United States and global markets experienced significant declines in value resulting from uncertainty caused by the world-wide coronavirus pandemic. The ABTA is closely monitoring the investment portfolio and its liquidity and are actively working to minimize the impact of these declines. These [audited] financial statements do not include adjustments to fair value that have resulted from these declines.

"On May 1, 2020, the ABTA obtained a $439,000 loan through the United States Small Business Administration's Paycheck Protection Program. The loan matures in May 2022, is uncollateralized, and bears interest at 1.0%; however, payment of principal and interest are deferred until the ABTA submits its application for loan forgiveness, as the loan may be eligible for forgiveness if certain conditions regarding the use of the loan proceeds are met."

Related Articles

No related articles found